Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.

Front Clin Diabetes Healthc · 2022 · PMC10012153 · PMID 36992737

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.2360

boldest claim

The sentences

borderline significancep = 0.05actually significant

However, there was a borderline significance increase in IDegAsp requirement for the whole group at the two-year follow-up ( p = 0.05).

also in 1,042 other papers

did not reach statistical significancep = 0.236not close (p > 0.1)

Although HbA1c significantly decreased in patients using two doses of insulin ( p < 0.01), the same decrease did not reach statistical significance in patients who participated in BB therapy ( p = 0.236).

also in 20,614 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.